MedTrace Logo

Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation

NCT02470208 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2017-09-19

No results posted yet for this study

Summary

The purpose of this study is to evaluate the ability of the T-SPOT.CMV assay to determine immune competence against CMV infection in stem cell transplantation.

To determine the utility of the T-SPOT.CMV assay used before transplantation to determine immune competence against subsequent CMV reactivation and to determine the utility of the T-SPOT.CMV assay used after transplantation to determine immune competence against subsequent CMV reactivation.

Conditions

Sponsors & Collaborators

  • Oxford Immunotec

    lead INDUSTRY

Principal Investigators

  • Roy F Chemaly, MD · The University of Texas MD Anderson Cancer Center

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • United States
  • Canada
  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02470208 on ClinicalTrials.gov